nodes	percent_of_prediction	percent_of_DWPC	metapath
Metolazone—SLC12A3—respiratory system—chronic obstructive pulmonary disease	0.00584	0.178	CbGeAlD
Metolazone—CA7—trachea—chronic obstructive pulmonary disease	0.0044	0.134	CbGeAlD
Metolazone—CA12—respiratory system—chronic obstructive pulmonary disease	0.00387	0.118	CbGeAlD
Metolazone—CA12—connective tissue—chronic obstructive pulmonary disease	0.00341	0.104	CbGeAlD
Metolazone—SLC12A3—lung—chronic obstructive pulmonary disease	0.0031	0.0944	CbGeAlD
Metolazone—CA12—trachea—chronic obstructive pulmonary disease	0.00286	0.0872	CbGeAlD
Metolazone—Tension—Formoterol—chronic obstructive pulmonary disease	0.00279	0.00288	CcSEcCtD
Metolazone—Tension—Arformoterol—chronic obstructive pulmonary disease	0.00279	0.00288	CcSEcCtD
Metolazone—Dysgeusia—Formoterol—chronic obstructive pulmonary disease	0.00278	0.00287	CcSEcCtD
Metolazone—Dysgeusia—Arformoterol—chronic obstructive pulmonary disease	0.00278	0.00287	CcSEcCtD
Metolazone—Chills—Salbutamol—chronic obstructive pulmonary disease	0.00276	0.00286	CcSEcCtD
Metolazone—Nervousness—Arformoterol—chronic obstructive pulmonary disease	0.00276	0.00285	CcSEcCtD
Metolazone—Nervousness—Formoterol—chronic obstructive pulmonary disease	0.00276	0.00285	CcSEcCtD
Metolazone—Insomnia—Aminophylline—chronic obstructive pulmonary disease	0.00275	0.00285	CcSEcCtD
Metolazone—Back pain—Arformoterol—chronic obstructive pulmonary disease	0.00275	0.00284	CcSEcCtD
Metolazone—Back pain—Formoterol—chronic obstructive pulmonary disease	0.00275	0.00284	CcSEcCtD
Metolazone—Muscle spasms—Arformoterol—chronic obstructive pulmonary disease	0.00273	0.00282	CcSEcCtD
Metolazone—Muscle spasms—Formoterol—chronic obstructive pulmonary disease	0.00273	0.00282	CcSEcCtD
Metolazone—Nausea—Roflumilast—chronic obstructive pulmonary disease	0.00271	0.0028	CcSEcCtD
Metolazone—Dyspepsia—Aminophylline—chronic obstructive pulmonary disease	0.00268	0.00277	CcSEcCtD
Metolazone—Muscle spasms—Montelukast—chronic obstructive pulmonary disease	0.00267	0.00276	CcSEcCtD
Metolazone—Decreased appetite—Aminophylline—chronic obstructive pulmonary disease	0.00265	0.00274	CcSEcCtD
Metolazone—Flatulence—Salbutamol—chronic obstructive pulmonary disease	0.00264	0.00273	CcSEcCtD
Metolazone—Ill-defined disorder—Formoterol—chronic obstructive pulmonary disease	0.00263	0.00272	CcSEcCtD
Metolazone—Ill-defined disorder—Arformoterol—chronic obstructive pulmonary disease	0.00263	0.00272	CcSEcCtD
Metolazone—Tension—Salbutamol—chronic obstructive pulmonary disease	0.00263	0.00272	CcSEcCtD
Metolazone—Dysgeusia—Salbutamol—chronic obstructive pulmonary disease	0.00263	0.00271	CcSEcCtD
Metolazone—Musculoskeletal discomfort—Tiotropium—chronic obstructive pulmonary disease	0.00262	0.0027	CcSEcCtD
Metolazone—Agitation—Formoterol—chronic obstructive pulmonary disease	0.00261	0.0027	CcSEcCtD
Metolazone—Agitation—Arformoterol—chronic obstructive pulmonary disease	0.00261	0.0027	CcSEcCtD
Metolazone—Nervousness—Salbutamol—chronic obstructive pulmonary disease	0.0026	0.00269	CcSEcCtD
Metolazone—Insomnia—Tiotropium—chronic obstructive pulmonary disease	0.0026	0.00269	CcSEcCtD
Metolazone—Back pain—Salbutamol—chronic obstructive pulmonary disease	0.00259	0.00268	CcSEcCtD
Metolazone—Paraesthesia—Tiotropium—chronic obstructive pulmonary disease	0.00258	0.00267	CcSEcCtD
Metolazone—Muscle spasms—Salbutamol—chronic obstructive pulmonary disease	0.00258	0.00267	CcSEcCtD
Metolazone—Malaise—Formoterol—chronic obstructive pulmonary disease	0.00256	0.00265	CcSEcCtD
Metolazone—Malaise—Arformoterol—chronic obstructive pulmonary disease	0.00256	0.00265	CcSEcCtD
Metolazone—Agitation—Montelukast—chronic obstructive pulmonary disease	0.00256	0.00264	CcSEcCtD
Metolazone—Dyspepsia—Tiotropium—chronic obstructive pulmonary disease	0.00253	0.00261	CcSEcCtD
Metolazone—Palpitations—Arformoterol—chronic obstructive pulmonary disease	0.00251	0.00259	CcSEcCtD
Metolazone—Palpitations—Formoterol—chronic obstructive pulmonary disease	0.00251	0.00259	CcSEcCtD
Metolazone—Gastrointestinal pain—Aminophylline—chronic obstructive pulmonary disease	0.00249	0.00257	CcSEcCtD
Metolazone—Ill-defined disorder—Salbutamol—chronic obstructive pulmonary disease	0.00249	0.00257	CcSEcCtD
Metolazone—Cough—Formoterol—chronic obstructive pulmonary disease	0.00248	0.00256	CcSEcCtD
Metolazone—Cough—Arformoterol—chronic obstructive pulmonary disease	0.00248	0.00256	CcSEcCtD
Metolazone—Agitation—Salbutamol—chronic obstructive pulmonary disease	0.00246	0.00255	CcSEcCtD
Metolazone—Palpitations—Montelukast—chronic obstructive pulmonary disease	0.00246	0.00254	CcSEcCtD
Metolazone—Constipation—Tiotropium—chronic obstructive pulmonary disease	0.00246	0.00254	CcSEcCtD
Metolazone—Hypertension—Arformoterol—chronic obstructive pulmonary disease	0.00245	0.00253	CcSEcCtD
Metolazone—Hypertension—Formoterol—chronic obstructive pulmonary disease	0.00245	0.00253	CcSEcCtD
Metolazone—Skin exfoliation—Prednisone—chronic obstructive pulmonary disease	0.00244	0.00252	CcSEcCtD
Metolazone—Cough—Montelukast—chronic obstructive pulmonary disease	0.00243	0.00251	CcSEcCtD
Metolazone—Urticaria—Aminophylline—chronic obstructive pulmonary disease	0.00242	0.0025	CcSEcCtD
Metolazone—Malaise—Salbutamol—chronic obstructive pulmonary disease	0.00242	0.0025	CcSEcCtD
Metolazone—Arthralgia—Arformoterol—chronic obstructive pulmonary disease	0.00242	0.0025	CcSEcCtD
Metolazone—Chest pain—Formoterol—chronic obstructive pulmonary disease	0.00242	0.0025	CcSEcCtD
Metolazone—Chest pain—Arformoterol—chronic obstructive pulmonary disease	0.00242	0.0025	CcSEcCtD
Metolazone—Arthralgia—Formoterol—chronic obstructive pulmonary disease	0.00242	0.0025	CcSEcCtD
Metolazone—Anxiety—Formoterol—chronic obstructive pulmonary disease	0.00241	0.00249	CcSEcCtD
Metolazone—Anxiety—Arformoterol—chronic obstructive pulmonary disease	0.00241	0.00249	CcSEcCtD
Metolazone—Vertigo—Salbutamol—chronic obstructive pulmonary disease	0.00241	0.00249	CcSEcCtD
Metolazone—Abdominal pain—Aminophylline—chronic obstructive pulmonary disease	0.00241	0.00249	CcSEcCtD
Metolazone—Syncope—Salbutamol—chronic obstructive pulmonary disease	0.0024	0.00249	CcSEcCtD
Metolazone—Neuropathy—Prednisone—chronic obstructive pulmonary disease	0.0024	0.00248	CcSEcCtD
Metolazone—CA4—respiratory system—chronic obstructive pulmonary disease	0.0024	0.073	CbGeAlD
Metolazone—Discomfort—Formoterol—chronic obstructive pulmonary disease	0.00239	0.00247	CcSEcCtD
Metolazone—Discomfort—Arformoterol—chronic obstructive pulmonary disease	0.00239	0.00247	CcSEcCtD
Metolazone—Palpitations—Salbutamol—chronic obstructive pulmonary disease	0.00237	0.00245	CcSEcCtD
Metolazone—Arthralgia—Montelukast—chronic obstructive pulmonary disease	0.00237	0.00245	CcSEcCtD
Metolazone—Dry mouth—Formoterol—chronic obstructive pulmonary disease	0.00236	0.00244	CcSEcCtD
Metolazone—Dry mouth—Arformoterol—chronic obstructive pulmonary disease	0.00236	0.00244	CcSEcCtD
Metolazone—Anxiety—Montelukast—chronic obstructive pulmonary disease	0.00236	0.00244	CcSEcCtD
Metolazone—Loss of consciousness—Salbutamol—chronic obstructive pulmonary disease	0.00236	0.00244	CcSEcCtD
Metolazone—Gastrointestinal pain—Tiotropium—chronic obstructive pulmonary disease	0.00235	0.00243	CcSEcCtD
Metolazone—Dry skin—Prednisolone—chronic obstructive pulmonary disease	0.00234	0.00242	CcSEcCtD
Metolazone—Cough—Salbutamol—chronic obstructive pulmonary disease	0.00234	0.00242	CcSEcCtD
Metolazone—Hypertension—Salbutamol—chronic obstructive pulmonary disease	0.00231	0.00239	CcSEcCtD
Metolazone—Chest pain—Salbutamol—chronic obstructive pulmonary disease	0.00228	0.00236	CcSEcCtD
Metolazone—Arthralgia—Salbutamol—chronic obstructive pulmonary disease	0.00228	0.00236	CcSEcCtD
Metolazone—Urticaria—Tiotropium—chronic obstructive pulmonary disease	0.00228	0.00236	CcSEcCtD
Metolazone—Anxiety—Salbutamol—chronic obstructive pulmonary disease	0.00227	0.00235	CcSEcCtD
Metolazone—Abdominal pain—Tiotropium—chronic obstructive pulmonary disease	0.00227	0.00235	CcSEcCtD
Metolazone—Discomfort—Salbutamol—chronic obstructive pulmonary disease	0.00226	0.00233	CcSEcCtD
Metolazone—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.00224	0.00232	CcSEcCtD
Metolazone—Dry mouth—Salbutamol—chronic obstructive pulmonary disease	0.00223	0.00231	CcSEcCtD
Metolazone—Thrombocytopenia—Montelukast—chronic obstructive pulmonary disease	0.00222	0.0023	CcSEcCtD
Metolazone—Abdominal distension—Prednisolone—chronic obstructive pulmonary disease	0.00222	0.0023	CcSEcCtD
Metolazone—Pancreatitis—Prednisolone—chronic obstructive pulmonary disease	0.00216	0.00224	CcSEcCtD
Metolazone—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.00215	0.00223	CcSEcCtD
Metolazone—Shock—Salbutamol—chronic obstructive pulmonary disease	0.00215	0.00223	CcSEcCtD
Metolazone—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.00212	0.00219	CcSEcCtD
Metolazone—Musculoskeletal discomfort—Arformoterol—chronic obstructive pulmonary disease	0.00211	0.00218	CcSEcCtD
Metolazone—Musculoskeletal discomfort—Formoterol—chronic obstructive pulmonary disease	0.00211	0.00218	CcSEcCtD
Metolazone—Insomnia—Formoterol—chronic obstructive pulmonary disease	0.0021	0.00217	CcSEcCtD
Metolazone—Insomnia—Arformoterol—chronic obstructive pulmonary disease	0.0021	0.00217	CcSEcCtD
Metolazone—Anorexia—Salbutamol—chronic obstructive pulmonary disease	0.00209	0.00216	CcSEcCtD
Metolazone—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.00208	0.00215	CcSEcCtD
Metolazone—Vascular purpura—Prednisone—chronic obstructive pulmonary disease	0.00207	0.00214	CcSEcCtD
Metolazone—Musculoskeletal discomfort—Montelukast—chronic obstructive pulmonary disease	0.00207	0.00214	CcSEcCtD
Metolazone—Somnolence—Arformoterol—chronic obstructive pulmonary disease	0.00206	0.00213	CcSEcCtD
Metolazone—Somnolence—Formoterol—chronic obstructive pulmonary disease	0.00206	0.00213	CcSEcCtD
Metolazone—CA12—lung—chronic obstructive pulmonary disease	0.00205	0.0626	CbGeAlD
Metolazone—Insomnia—Montelukast—chronic obstructive pulmonary disease	0.00205	0.00212	CcSEcCtD
Metolazone—Dyspepsia—Formoterol—chronic obstructive pulmonary disease	0.00204	0.00211	CcSEcCtD
Metolazone—Dyspepsia—Arformoterol—chronic obstructive pulmonary disease	0.00204	0.00211	CcSEcCtD
Metolazone—Paraesthesia—Montelukast—chronic obstructive pulmonary disease	0.00204	0.00211	CcSEcCtD
Metolazone—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.00203	0.0021	CcSEcCtD
Metolazone—Somnolence—Montelukast—chronic obstructive pulmonary disease	0.00202	0.00209	CcSEcCtD
Metolazone—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.00201	0.00208	CcSEcCtD
Metolazone—Dyspepsia—Montelukast—chronic obstructive pulmonary disease	0.002	0.00207	CcSEcCtD
Metolazone—Fatigue—Formoterol—chronic obstructive pulmonary disease	0.002	0.00207	CcSEcCtD
Metolazone—Fatigue—Arformoterol—chronic obstructive pulmonary disease	0.002	0.00207	CcSEcCtD
Metolazone—Musculoskeletal discomfort—Salbutamol—chronic obstructive pulmonary disease	0.00199	0.00206	CcSEcCtD
Metolazone—Pain—Formoterol—chronic obstructive pulmonary disease	0.00198	0.00205	CcSEcCtD
Metolazone—Constipation—Arformoterol—chronic obstructive pulmonary disease	0.00198	0.00205	CcSEcCtD
Metolazone—Pain—Arformoterol—chronic obstructive pulmonary disease	0.00198	0.00205	CcSEcCtD
Metolazone—Constipation—Formoterol—chronic obstructive pulmonary disease	0.00198	0.00205	CcSEcCtD
Metolazone—Insomnia—Salbutamol—chronic obstructive pulmonary disease	0.00198	0.00205	CcSEcCtD
Metolazone—Paraesthesia—Salbutamol—chronic obstructive pulmonary disease	0.00196	0.00203	CcSEcCtD
Metolazone—Fatigue—Montelukast—chronic obstructive pulmonary disease	0.00196	0.00202	CcSEcCtD
Metolazone—Somnolence—Salbutamol—chronic obstructive pulmonary disease	0.00195	0.00201	CcSEcCtD
Metolazone—Pain—Montelukast—chronic obstructive pulmonary disease	0.00194	0.00201	CcSEcCtD
Metolazone—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.00194	0.002	CcSEcCtD
Metolazone—Neuropathy peripheral—Prednisolone—chronic obstructive pulmonary disease	0.00193	0.00199	CcSEcCtD
Metolazone—Dyspepsia—Salbutamol—chronic obstructive pulmonary disease	0.00193	0.00199	CcSEcCtD
Metolazone—Purpura—Prednisone—chronic obstructive pulmonary disease	0.00193	0.00199	CcSEcCtD
Metolazone—Rash—Aminophylline—chronic obstructive pulmonary disease	0.00192	0.00199	CcSEcCtD
Metolazone—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.00192	0.00198	CcSEcCtD
Metolazone—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	0.00191	0.00197	CcSEcCtD
Metolazone—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	0.00191	0.00197	CcSEcCtD
Metolazone—Headache—Aminophylline—chronic obstructive pulmonary disease	0.00191	0.00197	CcSEcCtD
Metolazone—Decreased appetite—Salbutamol—chronic obstructive pulmonary disease	0.0019	0.00197	CcSEcCtD
Metolazone—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.0019	0.00196	CcSEcCtD
Metolazone—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	0.0019	0.00196	CcSEcCtD
Metolazone—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	0.0019	0.00196	CcSEcCtD
Metolazone—Lethargy—Prednisone—chronic obstructive pulmonary disease	0.00189	0.00196	CcSEcCtD
Metolazone—Fatigue—Salbutamol—chronic obstructive pulmonary disease	0.00189	0.00195	CcSEcCtD
Metolazone—Pain—Salbutamol—chronic obstructive pulmonary disease	0.00187	0.00193	CcSEcCtD
Metolazone—Constipation—Salbutamol—chronic obstructive pulmonary disease	0.00187	0.00193	CcSEcCtD
Metolazone—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	0.00186	0.00192	CcSEcCtD
Metolazone—CA5B—lung—chronic obstructive pulmonary disease	0.00184	0.0562	CbGeAlD
Metolazone—Urticaria—Formoterol—chronic obstructive pulmonary disease	0.00184	0.0019	CcSEcCtD
Metolazone—Urticaria—Arformoterol—chronic obstructive pulmonary disease	0.00184	0.0019	CcSEcCtD
Metolazone—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	0.00183	0.00189	CcSEcCtD
Metolazone—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	0.00183	0.00189	CcSEcCtD
Metolazone—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.00183	0.00189	CcSEcCtD
Metolazone—Rash—Tiotropium—chronic obstructive pulmonary disease	0.00181	0.00187	CcSEcCtD
Metolazone—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.00181	0.00187	CcSEcCtD
Metolazone—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.00181	0.00187	CcSEcCtD
Metolazone—Urticaria—Montelukast—chronic obstructive pulmonary disease	0.0018	0.00186	CcSEcCtD
Metolazone—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	0.0018	0.00186	CcSEcCtD
Metolazone—Headache—Tiotropium—chronic obstructive pulmonary disease	0.0018	0.00186	CcSEcCtD
Metolazone—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	0.00179	0.00186	CcSEcCtD
Metolazone—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	0.00179	0.00185	CcSEcCtD
Metolazone—CA4—trachea—chronic obstructive pulmonary disease	0.00177	0.054	CbGeAlD
Metolazone—Urticaria—Salbutamol—chronic obstructive pulmonary disease	0.00174	0.0018	CcSEcCtD
Metolazone—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	0.00173	0.00179	CcSEcCtD
Metolazone—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.00171	0.00177	CcSEcCtD
Metolazone—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.00171	0.00177	CcSEcCtD
Metolazone—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.00171	0.00176	CcSEcCtD
Metolazone—Dry skin—Prednisone—chronic obstructive pulmonary disease	0.0017	0.00176	CcSEcCtD
Metolazone—Hypokalaemia—Prednisone—chronic obstructive pulmonary disease	0.00169	0.00175	CcSEcCtD
Metolazone—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.00167	0.00173	CcSEcCtD
Metolazone—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.00166	0.00172	CcSEcCtD
Metolazone—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.00166	0.00172	CcSEcCtD
Metolazone—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.00164	0.0017	CcSEcCtD
Metolazone—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.00164	0.0017	CcSEcCtD
Metolazone—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.00163	0.00168	CcSEcCtD
Metolazone—Abdominal distension—Prednisone—chronic obstructive pulmonary disease	0.00161	0.00167	CcSEcCtD
Metolazone—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.00161	0.00167	CcSEcCtD
Metolazone—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.00161	0.00166	CcSEcCtD
Metolazone—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.00159	0.00164	CcSEcCtD
Metolazone—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.00159	0.00164	CcSEcCtD
Metolazone—Pancreatitis—Prednisone—chronic obstructive pulmonary disease	0.00157	0.00163	CcSEcCtD
Metolazone—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.00157	0.00162	CcSEcCtD
Metolazone—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.00155	0.00161	CcSEcCtD
Metolazone—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.00155	0.0016	CcSEcCtD
Metolazone—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.00153	0.00158	CcSEcCtD
Metolazone—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.00153	0.00158	CcSEcCtD
Metolazone—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.0015	0.00155	CcSEcCtD
Metolazone—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.0015	0.00155	CcSEcCtD
Metolazone—Erectile dysfunction—Prednisone—chronic obstructive pulmonary disease	0.00148	0.00153	CcSEcCtD
Metolazone—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.00147	0.00152	CcSEcCtD
Metolazone—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.00147	0.00152	CcSEcCtD
Metolazone—Rash—Arformoterol—chronic obstructive pulmonary disease	0.00146	0.00151	CcSEcCtD
Metolazone—Rash—Formoterol—chronic obstructive pulmonary disease	0.00146	0.00151	CcSEcCtD
Metolazone—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.00146	0.00151	CcSEcCtD
Metolazone—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.00146	0.00151	CcSEcCtD
Metolazone—Headache—Arformoterol—chronic obstructive pulmonary disease	0.00145	0.0015	CcSEcCtD
Metolazone—Headache—Formoterol—chronic obstructive pulmonary disease	0.00145	0.0015	CcSEcCtD
Metolazone—Vision blurred—Prednisolone—chronic obstructive pulmonary disease	0.00145	0.0015	CcSEcCtD
Metolazone—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.00145	0.0015	CcSEcCtD
Metolazone—Hyperglycaemia—Prednisone—chronic obstructive pulmonary disease	0.00145	0.0015	CcSEcCtD
Metolazone—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.00144	0.00149	CcSEcCtD
Metolazone—Rash—Montelukast—chronic obstructive pulmonary disease	0.00143	0.00148	CcSEcCtD
Metolazone—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.00143	0.00148	CcSEcCtD
Metolazone—Ill-defined disorder—Prednisolone—chronic obstructive pulmonary disease	0.00143	0.00148	CcSEcCtD
Metolazone—Headache—Montelukast—chronic obstructive pulmonary disease	0.00142	0.00147	CcSEcCtD
Metolazone—Neuropathy peripheral—Prednisone—chronic obstructive pulmonary disease	0.0014	0.00145	CcSEcCtD
Metolazone—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.00139	0.00144	CcSEcCtD
Metolazone—Malaise—Prednisolone—chronic obstructive pulmonary disease	0.00139	0.00143	CcSEcCtD
Metolazone—Vertigo—Prednisolone—chronic obstructive pulmonary disease	0.00138	0.00143	CcSEcCtD
Metolazone—Rash—Salbutamol—chronic obstructive pulmonary disease	0.00138	0.00143	CcSEcCtD
Metolazone—Syncope—Prednisolone—chronic obstructive pulmonary disease	0.00138	0.00143	CcSEcCtD
Metolazone—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.00138	0.00143	CcSEcCtD
Metolazone—Nausea—Formoterol—chronic obstructive pulmonary disease	0.00138	0.00142	CcSEcCtD
Metolazone—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.00138	0.00142	CcSEcCtD
Metolazone—Headache—Salbutamol—chronic obstructive pulmonary disease	0.00137	0.00142	CcSEcCtD
Metolazone—Loss of consciousness—Prednisolone—chronic obstructive pulmonary disease	0.00135	0.0014	CcSEcCtD
Metolazone—Nausea—Montelukast—chronic obstructive pulmonary disease	0.00135	0.00139	CcSEcCtD
Metolazone—Hypertension—Prednisolone—chronic obstructive pulmonary disease	0.00133	0.00137	CcSEcCtD
Metolazone—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.0013	0.00134	CcSEcCtD
Metolazone—Discomfort—Prednisolone—chronic obstructive pulmonary disease	0.00129	0.00134	CcSEcCtD
Metolazone—CA4—lung—chronic obstructive pulmonary disease	0.00127	0.0388	CbGeAlD
Metolazone—Shock—Prednisolone—chronic obstructive pulmonary disease	0.00123	0.00128	CcSEcCtD
Metolazone—Insomnia—Prednisolone—chronic obstructive pulmonary disease	0.00114	0.00117	CcSEcCtD
Metolazone—Paraesthesia—Prednisolone—chronic obstructive pulmonary disease	0.00113	0.00117	CcSEcCtD
Metolazone—Pain—Prednisolone—chronic obstructive pulmonary disease	0.00107	0.00111	CcSEcCtD
Metolazone—Vision blurred—Prednisone—chronic obstructive pulmonary disease	0.00105	0.00109	CcSEcCtD
Metolazone—Ill-defined disorder—Prednisone—chronic obstructive pulmonary disease	0.00104	0.00107	CcSEcCtD
Metolazone—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	0.00103	0.00107	CcSEcCtD
Metolazone—Anaemia—Prednisone—chronic obstructive pulmonary disease	0.00103	0.00107	CcSEcCtD
Metolazone—Agitation—Prednisone—chronic obstructive pulmonary disease	0.00103	0.00106	CcSEcCtD
Metolazone—Malaise—Prednisone—chronic obstructive pulmonary disease	0.00101	0.00104	CcSEcCtD
Metolazone—Vertigo—Prednisone—chronic obstructive pulmonary disease	0.001	0.00104	CcSEcCtD
Metolazone—Syncope—Prednisone—chronic obstructive pulmonary disease	0.001	0.00104	CcSEcCtD
Metolazone—Urticaria—Prednisolone—chronic obstructive pulmonary disease	0.000997	0.00103	CcSEcCtD
Metolazone—Loss of consciousness—Prednisone—chronic obstructive pulmonary disease	0.000982	0.00102	CcSEcCtD
Metolazone—Hypertension—Prednisone—chronic obstructive pulmonary disease	0.000965	0.000998	CcSEcCtD
Metolazone—Arthralgia—Prednisone—chronic obstructive pulmonary disease	0.000951	0.000984	CcSEcCtD
Metolazone—Anxiety—Prednisone—chronic obstructive pulmonary disease	0.000948	0.00098	CcSEcCtD
Metolazone—Discomfort—Prednisone—chronic obstructive pulmonary disease	0.00094	0.000972	CcSEcCtD
Metolazone—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	0.000925	0.000956	CcSEcCtD
Metolazone—Shock—Prednisone—chronic obstructive pulmonary disease	0.000897	0.000928	CcSEcCtD
Metolazone—Anorexia—Prednisone—chronic obstructive pulmonary disease	0.000869	0.000899	CcSEcCtD
Metolazone—Musculoskeletal discomfort—Prednisone—chronic obstructive pulmonary disease	0.000831	0.000859	CcSEcCtD
Metolazone—Dizziness—Prednisolone—chronic obstructive pulmonary disease	0.00083	0.000858	CcSEcCtD
Metolazone—Insomnia—Prednisone—chronic obstructive pulmonary disease	0.000825	0.000853	CcSEcCtD
Metolazone—Paraesthesia—Prednisone—chronic obstructive pulmonary disease	0.000819	0.000847	CcSEcCtD
Metolazone—Dyspepsia—Prednisone—chronic obstructive pulmonary disease	0.000803	0.00083	CcSEcCtD
Metolazone—Decreased appetite—Prednisone—chronic obstructive pulmonary disease	0.000793	0.00082	CcSEcCtD
Metolazone—Rash—Prednisolone—chronic obstructive pulmonary disease	0.000791	0.000818	CcSEcCtD
Metolazone—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	0.000791	0.000817	CcSEcCtD
Metolazone—Fatigue—Prednisone—chronic obstructive pulmonary disease	0.000786	0.000813	CcSEcCtD
Metolazone—Headache—Prednisolone—chronic obstructive pulmonary disease	0.000786	0.000813	CcSEcCtD
Metolazone—Constipation—Prednisone—chronic obstructive pulmonary disease	0.00078	0.000806	CcSEcCtD
Metolazone—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	0.000752	0.000777	CcSEcCtD
Metolazone—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	0.000746	0.000771	CcSEcCtD
Metolazone—Nausea—Prednisolone—chronic obstructive pulmonary disease	0.000745	0.000771	CcSEcCtD
Metolazone—Urticaria—Prednisone—chronic obstructive pulmonary disease	0.000725	0.000749	CcSEcCtD
Metolazone—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	0.000721	0.000745	CcSEcCtD
Metolazone—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	0.000672	0.000695	CcSEcCtD
Metolazone—Asthenia—Prednisone—chronic obstructive pulmonary disease	0.000654	0.000677	CcSEcCtD
Metolazone—Pruritus—Prednisone—chronic obstructive pulmonary disease	0.000645	0.000667	CcSEcCtD
Metolazone—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	0.000624	0.000645	CcSEcCtD
Metolazone—Dizziness—Prednisone—chronic obstructive pulmonary disease	0.000603	0.000624	CcSEcCtD
Metolazone—Vomiting—Prednisone—chronic obstructive pulmonary disease	0.00058	0.0006	CcSEcCtD
Metolazone—Rash—Prednisone—chronic obstructive pulmonary disease	0.000575	0.000595	CcSEcCtD
Metolazone—Dermatitis—Prednisone—chronic obstructive pulmonary disease	0.000574	0.000594	CcSEcCtD
Metolazone—Headache—Prednisone—chronic obstructive pulmonary disease	0.000571	0.000591	CcSEcCtD
Metolazone—Nausea—Prednisone—chronic obstructive pulmonary disease	0.000542	0.00056	CcSEcCtD
